I
Opus Genetics, Inc.
IRD · NASDAQ · Healthcare · 298M
Closing price
$4.65
+4.26% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
188.5×
Enterprise value / EBITDAEV/EBITDA
-59.2×
Free cash flow yieldFCF yield
-1.2%
Return on equityROE
-323.1%
Operating margin
-271.9%
Net debt / EBITDAbalance-sheet strength
0.9×
Interest coverage
-26.3×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.